Publications by authors named "Janine E Polifka"

17Publications

Assessment of developmental risk information on medicines for inclusion on the WHO's Essential Medicines List.

Int Health 2019 11;11(6):513-519

Center for Epidemiology and Environmental Health, CEOH, LLC, Washington, DC, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/inthealth/ihz006DOI Listing
November 2019

Thomas H. Shepard, M.D., pioneer in embryology and teratology.

Am J Med Genet A 2017 Jun 20;173(6):1465-1466. Epub 2017 Mar 20.

Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajmg.a.38103DOI Listing
June 2017

Should pregnant women be included in phase IV clinical drug trials?

Am J Obstet Gynecol 2015 Dec 23;213(6):810-5. Epub 2015 May 23.

Department of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine, University of Tennessee Medical Center, Knoxville, TN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ajog.2015.05.047DOI Listing
December 2015

Is there an embryopathy associated with first-trimester exposure to angiotensin-converting enzyme inhibitors and angiotensin receptor antagonists? A critical review of the evidence.

Authors:
Janine E Polifka

Birth Defects Res A Clin Mol Teratol 2012 Aug 17;94(8):576-98. Epub 2012 Jul 17.

Department of Pediatrics, University of Washington, Seattle, Washington, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/bdra.23027DOI Listing
August 2012

Evolving knowledge of the teratogenicity of medications in human pregnancy.

Am J Med Genet C Semin Med Genet 2011 Aug 15;157C(3):175-82. Epub 2011 Jul 15.

University of Washington in Seattle, and Seattle Children's Hospital, 4800 Sand Point Way NE, Seattle, WA 98105-0371, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/ajmg.c.30313
Publisher Site
http://dx.doi.org/10.1002/ajmg.c.30313DOI Listing
August 2011

The art and science of teratogen risk communication.

Am J Med Genet C Semin Med Genet 2011 Aug 15;157C(3):227-33. Epub 2011 Jul 15.

Nebraska TeratogenInformation Service, 985440 Nebraska Medical Center, Omaha, NE 68198-544, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajmg.c.30308DOI Listing
August 2011

Safety of dermatologic drugs used in pregnant patients with psoriasis and other inflammatory skin diseases.

J Am Acad Dermatol 2008 Aug 14;59(2):295-315. Epub 2008 Apr 14.

Department of Pediatrics, Division of Dermatology, Rady Children's Hospital, University of California, San Diego, California, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S019096220800360
Publisher Site
http://dx.doi.org/10.1016/j.jaad.2008.03.018DOI Listing
August 2008

A survey of pregnant women using isotretinoin.

Birth Defects Res A Clin Mol Teratol 2005 Nov;73(11):881-7

Utah Department of Health, Division of Community and Family Health Services, Birth Defects and Genetics Program, Pregnancy RiskLine, Salt Lake City, 84114-4691, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/bdra.20197DOI Listing
November 2005

Addendum: sartan treatment during pregnancy.

Birth Defects Res A Clin Mol Teratol 2005 Nov;73(11):904-5

Department of Medical Genetics, University of British Columbia, Vancouver, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/bdra.20194DOI Listing
November 2005

Communicating risks during pregnancy: a workshop on the use of data from animal developmental toxicity studies in pregnancy labels for drugs.

Birth Defects Res A Clin Mol Teratol 2004 Jan;70(1):7-12

Department of Obstetrics and Gynecology, Georgetown University Medical Center, 3800 Reservoir Road NW, Washington, DC 20007-2119, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/bdra.10150DOI Listing
January 2004

Developmental toxicity of ribavirin/IFalpha combination therapy: is the label more dangerous than the drugs?

Birth Defects Res A Clin Mol Teratol 2003 Jan;67(1):8-12

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/bdra.10020DOI Listing
January 2003

Medical genetics: 1. Clinical teratology in the age of genomics.

CMAJ 2002 Aug;167(3):265-73

Department of Pediatrics, University of Washington, Seattle, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC117475PMC
August 2002

Teratogen update: azathioprine and 6-mercaptopurine.

Teratology 2002 May;65(5):240-61

TERIS Project, University of Washington, Seattle 98195-7920, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/tera.10043DOI Listing
May 2002

Developmental toxicity: web resources for evaluating risk in humans.

Toxicology 2002 Apr;173(1-2):35-65

Department of Pediatrics, TERIS Project, University of Washington, PO Box 357920, Seattle, WA 98195-7920, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0300-483x(02)00021-5DOI Listing
April 2002